Close

Form 6-K GLAXOSMITHKLINE PLC For: Oct 24

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. TSLA
5. SPY
6. INFY
7. SNV
8. SMCI
9. SLB
10. JWN


October 24, 2014 1:22 PM EDT

FORM 6-K
�
�
SECURITIES AND EXCHANGE COMMISSION(
Washington D.C. 20549
�
�
Report of Foreign Issuer
�
�
Pursuant to Rule 13a-16 or 15d-16 of(
the Securities Exchange Act of 1934
�
�
�
For period ending�October 2014
�
GlaxoSmithKline plc
(Name of registrant)(

�
�
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)(

�
�
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F(

�
�
Form 20-F x��� �Form 40-F(
�
--(
�
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.(

�
�
Yes����� No x
--
�

�
�
�
�
�


�
GlaxoSmithKline plc
�
�
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
�
In accordance with DTR 3.1.4R(1)(a) I give below details of changes in the interests of Mrs V A Whyte, a Person Discharging Managerial Responsibility, in the Ordinary Shares of GlaxoSmithKline plc (the "Company"):
�
The exercise of options over 2,249 Ordinary Shares on 24 October 2014, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of �11.23 per share, and the sale of 2,051 Ordinary Shares at a price of �14.08 per share on 24 October 2014.
�
The Company was advised of the transaction on 24 October 2014.
�
V A Whyte
Company Secretary
�
�
24 October 2014
�

�
�
�
�
�
�
�
�
�
SIGNATURES
�
�
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.(


�
�
GlaxoSmithKline plc
(Registrant)(

Date:�October 24,�2014�
�
�
By:�VICTORIA WHYTE
----------------------
�
�
Victoria�Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings